Nirvana Life Sciences Inc. (CSE:NIRV)
Canada
· Delayed Price · Currency is CAD 0.0700
-0.0300 (-30.00%)
At close: Nov 17, 2025
Nirvana Life Sciences Market Cap
Nirvana Life Sciences has a market cap or net worth of CAD 1.60 million as of December 5, 2025. Its market cap has decreased by -82.29% in one year.
Market Cap
1.60M
Enterprise Value
1.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since March 17, 2022, Nirvana Life Sciences's market cap has decreased from 4.27M to 1.60M, a decrease of -62.58%. That is a compound annual growth rate of -23.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 1.60M | -33.75% |
| Dec 27, 2024 | 2.41M | 150.00% |
| Dec 28, 2023 | 964.66K | -81.10% |
| Dec 19, 2022 | 5.10M | 19.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.50B |
| dentalcorp Holdings | 2.18B |
| Green Thumb Industries | 2.11B |
| Sienna Senior Living | 1.92B |
| Extendicare | 1.71B |
| Trulieve Cannabis | 1.43B |
| Cronos Group | 1.31B |
| WELL Health Technologies | 931.75M |